NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

53 hedge funds and large institutions have $49M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17K
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.2M
2
$6.5M
3
$6.46M
4
$2.95M
5
$2.17M
6
$2.05M
7
$1.78M
8
$1.77M
9
$1.39M
10
$1.01M
11
$870K
12
$849K
13
$805K
14
$723K
15
$625K
16
$416K
17
$364K
18
$344K
19
$340K
20
$293K
21
$288K
22
$288K
23
$278K
24
$230K
25
$182K